These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9420907)

  • 1. The many faces of completely regressed malignant melanoma.
    Barr RJ
    Pathology (Phila); 1994; 2(2):359-70. PubMed ID: 9420907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete regression of primary malignant melanoma.
    Emanuel PO; Mannion M; Phelps RG
    Am J Dermatopathol; 2008 Apr; 30(2):178-81. PubMed ID: 18360126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmoplastic neurotropic malignant melanoma.
    Carlson JA; Egbert BM
    Pathology (Phila); 1994; 2(2):339-57. PubMed ID: 9420906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thin melanomas.
    King R; Googe PB; Mihm MC
    Clin Lab Med; 2000 Dec; 20(4):713-29. PubMed ID: 11221511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immuno-diagnosis of malignant melanoma].
    Szekeres G; Battyáni Z
    Magy Onkol; 2003; 47(1):45-50. PubMed ID: 12704454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some remarks to the histological classification of malignant melanoma of the skin and its prognostic values.
    Svejda J; Mechl Z; Rejthar A
    Neoplasma; 1977; 24(4):425-30. PubMed ID: 904746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Completely regressed primary cutaneous malignant melanoma with nodal and/or visceral metastases: a report of 5 cases and assessment of the literature and diagnostic criteria.
    High WA; Stewart D; Wilbers CR; Cockerell CJ; Hoang MP; Fitzpatrick JE
    J Am Acad Dermatol; 2005 Jul; 53(1):89-100. PubMed ID: 15965428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features.
    Pizzichetta MA; Talamini R; Stanganelli I; Puddu P; Bono R; Argenziano G; Veronesi A; Trevisan G; Rabinovitz H; Soyer HP
    Br J Dermatol; 2004 Jun; 150(6):1117-24. PubMed ID: 15214897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
    Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation of regression in primary melanoma with sentinel lymph node status.
    Kaur C; Thomas RJ; Desai N; Green MA; Lovell D; Powell BW; Cook MG
    J Clin Pathol; 2008 Mar; 61(3):297-300. PubMed ID: 17675538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative activity in the progression of pigmented skin lesions, diagnostic and prognostic significance.
    Korabiowska M; Brinck U; Middel P; Brinkmann U; Berger H; Radzun HJ; Ruschenburg I; Droese M
    Anticancer Res; 2000; 20(3A):1781-5. PubMed ID: 10928107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma prognostic factors found in the dermatopathology report.
    Payette MJ; Katz M; Grant-Kels JM
    Clin Dermatol; 2009; 27(1):53-74. PubMed ID: 19095154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principles of dermatoscopy of pigmented skin lesions.
    Stolz W; Semmelmayer U; Johow K; Burgdorf WH
    Semin Cutan Med Surg; 2003 Mar; 22(1):9-20. PubMed ID: 12773010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the diagnosis of pigmented tumors of the skin and factors leading to a decision to excise. Dermatologists of the Postgraduate Association of Haute-Normandie].
    Collas H; Delbarre M; De Preville PA; Courville P; Neveu C; Dompmartin A; Balguerie X; Lemaistre B; Rzeznik JC; Thiebot B; Boullie MC; Bravard P; Michel Y; Krug M; Le Corvaisier-Pieto C; Young P; Thomine E; Boivin C; Ziade J; Pellerin A; Hellot MF; Leroy D; Lauret P; Benichou J; Joly P
    Ann Dermatol Venereol; 1999; 126(6-7):494-500. PubMed ID: 10495858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epiluminescence microscopy features of cutaneous malignant melanoma metastases.
    Schulz H
    Melanoma Res; 2000 Jun; 10(3):273-80. PubMed ID: 10890382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Ki-67 expression in cutaneous primary melanoma with prognosis in a prospective study: different correlation according to thickness.
    Moretti S; Spallanzani A; Chiarugi A; Fabiani M; Pinzi C
    J Am Acad Dermatol; 2001 Feb; 44(2):188-92. PubMed ID: 11174375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression and other factors of prognostic interest in malignant melanoma.
    Sagebiel R
    Arch Dermatol; 1985 Sep; 121(9):1125-6. PubMed ID: 4037836
    [No Abstract]   [Full Text] [Related]  

  • 18. Simulators of malignant melanoma of the skin.
    Cerroni L; Kerl H
    Eur J Dermatol; 1998 Sep; 8(6):388-96. PubMed ID: 9729049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual histological variants of cutaneous malignant melanoma with some clinical and possible prognostic correlations.
    Rongioletti F; Smoller BR
    J Cutan Pathol; 2005 Oct; 32(9):589-603. PubMed ID: 16176296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitiligo-like primary melanoma.
    Lugo-Somolinos A; Sánchez JL; Garcia ME
    Am J Dermatopathol; 2008 Oct; 30(5):451-4. PubMed ID: 18806487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.